167 related articles for article (PubMed ID: 16148025)
1. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites.
Stenina OI; Ustinov V; Krukovets I; Marinic T; Topol EJ; Plow EF
FASEB J; 2005 Nov; 19(13):1893-5. PubMed ID: 16148025
[TBL] [Abstract][Full Text] [Related]
2. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
[TBL] [Abstract][Full Text] [Related]
3. Association of Thrombospondin-1 (N700S) and Thrombospondin-4 (A387P) Gene Polymorphisms with the Incidence of Acute Myocardial Infarction in Egyptians.
Abdelmonem NA; Turky NO; Hashad IM; Abdel Rahman MF; El-Etriby A; Gad MZ
Curr Pharm Biotechnol; 2017; 18(13):1078-1087. PubMed ID: 29336258
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin binds to caldesmon in an antiparallel manner.
Wang E; Zhuang S; Kordowska J; Grabarek Z; Wang CL
Biochemistry; 1997 Dec; 36(48):15026-34. PubMed ID: 9398229
[TBL] [Abstract][Full Text] [Related]
5. Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2.
Misenheimer TM; Mosher DF
J Biol Chem; 2005 Dec; 280(50):41229-35. PubMed ID: 16246837
[TBL] [Abstract][Full Text] [Related]
6. Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding.
Hou J; Putkey JA; Hecht JT
Cell Calcium; 2000 Jun; 27(6):309-14. PubMed ID: 11013461
[TBL] [Abstract][Full Text] [Related]
7. Amino acid sequence of an immunogenic corneal stromal protein.
Liu SH; Gottsch JD
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):944-8. PubMed ID: 8603881
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells.
Stenina OI; Desai SY; Krukovets I; Kight K; Janigro D; Topol EJ; Plow EF
Circulation; 2003 Sep; 108(12):1514-9. PubMed ID: 12952849
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery disease and the thrombospondin single nucleotide polymorphisms.
Stenina OI; Byzova TV; Adams JC; McCarthy JJ; Topol EJ; Plow EF
Int J Biochem Cell Biol; 2004 Jun; 36(6):1013-30. PubMed ID: 15094117
[TBL] [Abstract][Full Text] [Related]
10. Modeling the mutational effects on calmodulin structure: prediction of alteration in the amino acid interactions.
Rashid A; Khurshid R; Begum M; Gul-e-Raana ; Latif M; Salim A
Biochem Biophys Res Commun; 2004 Apr; 317(2):363-9. PubMed ID: 15063766
[TBL] [Abstract][Full Text] [Related]
11. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
12. Probing site-specific calmodulin calcium and lanthanide affinity by grafting.
Ye Y; Lee HW; Yang W; Shealy S; Yang JJ
J Am Chem Soc; 2005 Mar; 127(11):3743-50. PubMed ID: 15771508
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1.
Zhou J; Rothman VL; Sargiannidou I; Dimitrov S; Qiu C; Smith E; Sheffield J; Sharma M; Tuszynski GP
J Cell Biochem; 2004 May; 92(1):125-46. PubMed ID: 15095410
[TBL] [Abstract][Full Text] [Related]
14. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic characterization of a high-affinity calmodulin-target peptide hybrid molecule.
Martin SR; Bayley PM; Brown SE; Porumb T; Zhang M; Ikura M
Biochemistry; 1996 Mar; 35(11):3508-17. PubMed ID: 8639501
[TBL] [Abstract][Full Text] [Related]
16. Electron paramagnetic resonance spectroscopy and molecular modelling of the interaction of myelin basic protein (MBP) with calmodulin (CaM)-diversity and conformational adaptability of MBP CaM-targets.
Polverini E; Boggs JM; Bates IR; Harauz G; Cavatorta P
J Struct Biol; 2004 Dec; 148(3):353-69. PubMed ID: 15522783
[TBL] [Abstract][Full Text] [Related]
17. Two-dimensional 1H nuclear magnetic resonance studies of the half-saturated (Ca2+)1 state of calbindin D9k. Further implications for the molecular basis of cooperative Ca2+ binding.
Carlström G; Chazin WJ
J Mol Biol; 1993 May; 231(2):415-30. PubMed ID: 8389885
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.
Koch W; Hoppmann P; de Waha A; Schömig A; Kastrati A
Hum Mol Genet; 2008 Apr; 17(8):1120-6. PubMed ID: 18178577
[TBL] [Abstract][Full Text] [Related]
19. The binding of myristoylated N-terminal nonapeptide from neuro-specific protein CAP-23/NAP-22 to calmodulin does not induce the globular structure observed for the calmodulin-nonmyristylated peptide complex.
Hayashi N; Izumi Y; Titani K; Matsushima N
Protein Sci; 2000 Oct; 9(10):1905-13. PubMed ID: 11106163
[TBL] [Abstract][Full Text] [Related]
20. The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.
Zwicker JI; Peyvandi F; Palla R; Lombardi R; Canciani MT; Cairo A; Ardissino D; Bernardinelli L; Bauer KA; Lawler J; Mannucci P
Blood; 2006 Aug; 108(4):1280-3. PubMed ID: 16684956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
